Nyxoah SA (NYXH) vs Zomedica Corp. (ZOMDF)

Nyxoah SA and Zomedica Corp. are both Medical Devices companies. Zomedica Corp. is the larger, with a market value of $95.4M against $82.6M — 1.2× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 31.3%. Zomedica Corp. has the higher net margin (−41.4% vs −446.4%) and the higher return on invested capital (−17.1% vs −117.8%). Across the 17 metrics below, Zomedica Corp. leads on 11 and Nyxoah SA on 6.

Valuation

Metric NYXH ZOMDF Medical Devices median
P/E n/m n/m 25.58
P/S 1.84 2.28 2.54
P/B 0.48 0.85 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 0.06 1.26 2.72
Earnings yield (311.11%) (18.00%) (12.82%)
Free cash flow yield (187.33%) (15.27%) (8.18%)

Profitability

Metric NYXH ZOMDF Medical Devices median
Gross margin 60.16% 63.96% 57.76%
Operating margin (391.25%) (45.43%) (15.07%)
Net margin (446.39%) (41.35%) (14.45%)
Free cash flow margin (344.99%) (34.81%) (3.88%)
Return on equity (124.41%) (14.28%) (10.35%)
Return on assets (68.23%) (13.01%) (17.26%)
Return on invested capital (117.82%) (17.12%) (5.27%)

Growth

Metric NYXH ZOMDF Medical Devices median
Revenue growth (TTM) 366.24% 31.33% 10.41%
EPS growth (last fiscal year) (36.22%) (60.00%) 28.17%
Revenue growth, 5-year CAGR 170.14% — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NYXH ZOMDF Medical Devices median
Debt to equity 0.72 0.00 0.04
Current ratio 2.38 6.09 2.74
Net debt to EBITDA 0.08 0.69 0.54

Dividend

Metric NYXH ZOMDF Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric NYXH ZOMDF Medical Devices median
Market cap 82.59m 95.35m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack